Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-01-02 @ 2:10 AM
Study NCT ID:
NCT04343651
Status:
COMPLETED
Last Update Posted:
2023-01-04
First Post:
2020-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19
Sponsor:
CytoDyn, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CD10_COVID-19
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None